148 related articles for article (PubMed ID: 10868477)
21. Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.
von Eckardstein A; Malinow MR; Upson B; Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
Arterioscler Thromb; 1994 Mar; 14(3):460-4. PubMed ID: 8123652
[TBL] [Abstract][Full Text] [Related]
22. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
Moghadasian MH; McManus BM; Frohlich JJ
Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.
Falcon CR; Cattaneo M; Panzeri D; Martinelli I; Mannucci PM
Arterioscler Thromb; 1994 Jul; 14(7):1080-3. PubMed ID: 8018663
[TBL] [Abstract][Full Text] [Related]
24. Hyperhomocyst(e)inemia in chronic stable renal transplant patients.
Machado DJ; Paula FJ; Sabbaga E; Ianhez LE
Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(5):161-8. PubMed ID: 11175576
[TBL] [Abstract][Full Text] [Related]
25. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
Sydow K; Böger RH
Z Kardiol; 2001 Jan; 90(1):1-11. PubMed ID: 11220081
[TBL] [Abstract][Full Text] [Related]
26. Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?
Virdis A; Ghiadoni L; Versari D; Salvetti G; Pinto S; Favilla S; Taddei S; Salvetti A
Curr Pharm Des; 2005; 11(17):2187-97. PubMed ID: 16026288
[TBL] [Abstract][Full Text] [Related]
27. Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Quehenberger F; Semmelrock J; Haas A
Ophthalmology; 2002 Jun; 109(6):1105-9. PubMed ID: 12045051
[TBL] [Abstract][Full Text] [Related]
28. Hyperhomocyst(e)inaemia in children with chronic renal failure.
Lilien M; Duran M; Van Hoeck K; Poll-The BT; Schröder C
Nephrol Dial Transplant; 1999 Feb; 14(2):366-8. PubMed ID: 10069190
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?
Kunz K; Petitjean P; Lisri M; Chantrel F; Koehl C; Wiesel ML; Cazenave JP; Moulin B; Hannedouche TP
Nephrol Dial Transplant; 1999 Aug; 14(8):1934-42. PubMed ID: 10462274
[TBL] [Abstract][Full Text] [Related]
30. Causes and consequences of hyperhomocyst(e)inemia.
Pietrzik K; Brönstrup A
Int J Vitam Nutr Res; 1997; 67(5):389-95. PubMed ID: 9350483
[TBL] [Abstract][Full Text] [Related]
31. Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans.
Yoo JH; Park JE; Hong KP; Lee SH; Kim DK; Lee WR; Park SC
Thromb Res; 1999 Apr; 94(1):45-52. PubMed ID: 10213180
[TBL] [Abstract][Full Text] [Related]
32. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.
Eikelboom JW; Lonn E; Genest J; Hankey G; Yusuf S
Ann Intern Med; 1999 Sep; 131(5):363-75. PubMed ID: 10475890
[TBL] [Abstract][Full Text] [Related]
33. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Sydow K; Schwedhelm E; Arakawa N; Bode-Böger SM; Tsikas D; Hornig B; Frölich JC; Böger RH
Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
[TBL] [Abstract][Full Text] [Related]
34. Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients.
Lanfredini M; Fiorina P; Peca MG; Veronelli A; Mello A; Astorri E; Dall'Aglio P; Craveri A
Metabolism; 1998 Aug; 47(8):915-21. PubMed ID: 9711985
[TBL] [Abstract][Full Text] [Related]
35. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.
Malinow MR; Nieto FJ; Szklo M; Chambless LE; Bond G
Circulation; 1993 Apr; 87(4):1107-13. PubMed ID: 8462139
[TBL] [Abstract][Full Text] [Related]
36. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
Lentz SR; Malinow MR; Piegors DJ; Bhopatkar-Teredesai M; Faraci FM; Heistad DD
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
[TBL] [Abstract][Full Text] [Related]
37. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
Stanger O; Weger M; Renner W; Konetschny R
Clin Chem Lab Med; 2001 Aug; 39(8):725-33. PubMed ID: 11592442
[TBL] [Abstract][Full Text] [Related]
38. Homocyst(e)ine, vitamins and genetic interactions in vascular disease.
Malinow MR
Can J Cardiol; 1999 Apr; 15 Suppl B():31B-34B. PubMed ID: 10350683
[TBL] [Abstract][Full Text] [Related]
39. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia.
Ubbink JB
J Inherit Metab Dis; 1997 Jun; 20(2):316-25. PubMed ID: 9211204
[TBL] [Abstract][Full Text] [Related]
40. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.
Henning BF; Zidek W; Riezler R; Graefe U; Tepel M
Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
